Healthcare Sales & Marketing Network News: atherosclerosis

Searching News Database: atherosclerosis

HSMN NewsFeed - 6 Oct 2021
BD Announces 510(k) Clearance of Expanded Indications for the Rotarex(TM) Atherectomy System
Devices Interventional FDA

HSMN NewsFeed - 4 Mar 2021
ControlRad(R) Announces FDA Clearance for ControlRad Select
Devices Interventional FDA Distribution

HSMN NewsFeed - 25 Jan 2021
Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals Product Launch

HSMN NewsFeed - 25 Nov 2020
Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy(TM) (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Nov 2020
Boston Scientific Receives FDA Approval for the Ranger(TM) Drug-Coated Balloon
Devices Interventional FDA Product Launch

HSMN NewsFeed - 6 Jan 2020
Vascular Graft Solutions Acquires the Intellectual Property Developed by Kipsbay Medical Inc.
Devices Interventional Acquisitions

HSMN NewsFeed - 31 Jul 2019
Results of the Pivotal Phase 3 Study of the Bempedoic Acid / Ezetimibe Combination Tablet Published in the European Journal of Preventative Cardiology Demonstrated Significant LDL-C Lowering
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Apr 2019
New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events in Adults with No Known Heart Disease
Diagnostics Cardiology

HSMN NewsFeed - 1 Apr 2019
Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio Targeting Innate Immune System
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 28 Feb 2019
Daiichi Sankyo Europe and Esperion Announce Validation of the Marketing Authorisation Application (MAA) for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Fixed Dose Combination Tablet
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 30 Jan 2019
CardioVax Announces Name Change to Abcentra
Biopharmaceuticals

HSMN NewsFeed - 19 Dec 2018
Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib in Progeria and Progeroid Laminopathies
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Oct 2018
Eiger BioPharmaceuticals Receives FDA Rare Pediatric Disease (RPD) Designation for Lonafarnib for the Treatment of Progeria and Progeroid Laminopathies and Plans NDA Filing in 2019
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Aug 2018
Prevencio Announces Data Demonstrating HART PAD(TM) Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patients
Diagnostics Cardiology

HSMN NewsFeed - 6 Aug 2018
AOBiome Therapeutics Announces the Expansion of its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2018
ANI Pharmaceuticals Announces Launch of Cholestyramine for Oral Suspension USP
Biopharmaceuticals Product Launch

HSMN NewsFeed - 16 May 2018
Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF)
Biopharmaceuticals Licensing Distribution

HSMN NewsFeed - 29 Jan 2018
gammaCore(R) Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients
Devices Neurology FDA

HSMN NewsFeed - 17 Jan 2018
Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST(R) for Prophylaxis of Hereditary Angioedema Attacks
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Nov 2017
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
Devices Endocrinology Personnel

HSMN NewsFeed - 29 Nov 2017
electroCore Completes $70 Million Series B Funding Round
Devices Neurology Venture Capital

HSMN NewsFeed - 27 Nov 2017
Pharming Submits Supplemental Biologics License Application to FDA for RUCONEST(R) for Prophylaxis of Hereditary Angioedema Attacks
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Oct 2017
FDA Approves New 10 mg Dosing for XARELTO(R) (rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism (VTE)
Biopharmaceuticals FDA

HSMN NewsFeed - 11 Sep 2017
electroCore Announces Results from gammaCore(R) (non-invasive vagus nerve stimulator) Study in Migraine at the 18th Congress of the International Headache Society
Devices Neurology

HSMN NewsFeed - 22 Aug 2017
Getinge announces full U.S. availability of Pulsar(R)-18 self-expanding stent from BIOTRONIK for patients with peripheral artery disease
Devices Interventional Product Launch

HSMN NewsFeed - 18 Apr 2017
FDA Releases gammaCore(R), the First Non-Invasive Vagus Nerve Stimulation Therapy Applied at the Neck for Acute Treatment of Pain Associated with Episodic Cluster Headache in Adult Patients
Devices FDA

HSMN NewsFeed - 20 Mar 2017
Landmark Outcomes Study Shows that Repatha(R) (evolocumab) Decreases LDL-C to Unprecedented Low Levels and Reduces Risk of Cardiovascular Events with No New Safety Issues
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Feb 2017
Amgen Announces Repatha(R) (Evolocumab) Significantly Reduced The Risk Of Cardiovascular Events In FOURIER Outcomes Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 8 Dec 2016
Pharming Announces Completion of Acquisition of All North American Commercialisation Rights for RUCONEST(R) From Valeant
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 14 Nov 2016
Technopath Clinical Diagnostics Launches its First Diagnostic Reagent Product, the i-plaq(TM) Test for Lp-PLA2
Diagnostics Cardiology Product Launch

HSMN NewsFeed - 20 Oct 2016
Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA(TM) Bioresorbable Scaffold for Peripheral Vascular Disease
Devices Interventional

HSMN NewsFeed - 29 Aug 2016
Regeneron and Sanofi Present Positive Phase 3 Investigational Data for Praluent(R) (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Aug 2016
New Repatha(R) (evolocumab) Analyses Show Efficacy and Safety Across Risk Groups in Results Presented at ESC Congress 2016
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Jul 2016
Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 4 Apr 2016
ANI Pharmaceuticals Closes Acquisition of Inderal(R) LA Assets
Biopharmaceuticals Cardiology Acquisitions

HSMN NewsFeed - 4 Feb 2016
Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha(R) (Evolocumab) In Statin-Intolerant Patients With High Cholesterol
Biopharmaceuticals

HSMN NewsFeed - 22 Jan 2016
Amgen's Repatha(R) (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol
Biopharmaceuticals Regulatory

HSMN NewsFeed - 5 Oct 2015
Boston Scientific Receives FDA Approval For SYNERGY(TM) Bioabsorbable Polymer Drug-Eluting Stent System
Devices Interventional Cardiology FDA

HSMN NewsFeed - 16 Sep 2015
Amgen To Acquire Privately-Held Dezima Pharma
Biopharmaceuticals Cardiology Mergers & Acquisitions

HSMN NewsFeed - 11 Sep 2015
Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha(TM) (Evolocumab)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 19 May 2015
Shockwave Medical Announces $40 Million in Funding for Novel Lithoplasty System to Treat Advanced Peripheral, Coronary Vascular and Aortic Valve Disease
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 3 Nov 2014
Salix and Pharming Announce the Launch of RUCONEST(R) in the U.S. for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)
Biopharmaceuticals Product Launch

HSMN NewsFeed - 18 Sep 2014
Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits
Devices Interventional Cardiology

HSMN NewsFeed - 21 Jul 2014
CorMatrix(R) Reports FDA Clearance of CorMatrix ECM(R) for Vascular Repair
Devices Regenerative Medicine FDA

HSMN NewsFeed - 17 Jul 2014
Salix and Pharming Announce FDA Approval of RUCONEST(R) for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Jul 2014
First Patient Enrolment in MASCOT Registry Represents Major Milestone for COMBO(TM) Dual Therapy Stent and OrbusNeich's Clinical Programme
Devices Interventional Cardiology

HSMN NewsFeed - 12 Jun 2014
Cardiovascular Systems Announces Plans for New Corporate Headquarters
Devices Interventional Cardiology

HSMN NewsFeed - 23 May 2014
OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2014
Genkyotex Announces New Senior Management and Board Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 May 2014
FDA Approves ZONTIVITY(TM) (vorapaxar), First-in-Class PAR-1 Antagonist, for the Reduction of Thrombotic Cardiovascular Events in Patients with a History of Heart Attack or with Peripheral Arterial Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 9 Apr 2014
CardioDx and Medison Israel Enter Into an Exclusive Corus(R) CAD Product Marketing and Sales Agreement
Diagnostics Cardiology Distribution

HSMN NewsFeed - 8 Apr 2014
AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 20 Jan 2014
Aegerion Pharmaceuticals' JUXTAPID(R) (lomitapide) Capsules Approved in Mexico for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 13 Jan 2014
Esperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr., M.D., DPhil, as Director
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 3 Dec 2013
Physicians Throughout U.S. Using Cardiovascular Systems’ New Technology to Treat Coronary Artery Disease
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 20 Nov 2013
MAQUET Cardiovascular Announces Study Results Demonstrating HEARTSTRING(R) Device Associated with Significant Reduction in Coronary Artery Bypass Stroke Risk
Devices Surgery Cardiology

HSMN NewsFeed - 22 Oct 2013
Cardiovascular Systems, Inc. Receives Coronary FDA Approval
Devices Interventional Cardiology FDA Product Launch

HSMN NewsFeed - 6 Sep 2013
LipoScience Announces Appointment Of William Cromwell, M.D., As Chief Medical Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 22 Aug 2013
diaDexus, Inc. Appoints Ralf Schoenbrunner to Senior Vice President, Research and Early Development
Diagnostics Cardiology Personnel

HSMN NewsFeed - 12 Jul 2013
Boston Scientific Launches Guidezilla(TM) Guide Extension Catheter in U.S. and Europe
Devices Interventional Cardiology FDA Product Launch

HSMN NewsFeed - 15 Mar 2013
Cardiovascular Systems Completes PMA Submission of Orbital Atherectomy System for Coronary Artery Disease Treatment
Devices Interventional Cardiology FDA

HSMN NewsFeed - 12 Mar 2013
Cordis Acquires Flexible Stenting Solutions, Inc.
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 8 Jan 2013
AtheroNova Names New Clinical Affairs Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 18 Dec 2012
AtheroNova Names New Chief Medical Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 3 Dec 2012
Spherix Announces Restructuring
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Sep 2012
Boston Scientific Launches Emerge(TM) PTCA Balloon Dilatation Catheter in the U.S.
Devices Interventional Cardiology FDA

HSMN NewsFeed - 26 Sep 2012
Merck Returns Global Marketing and Development Rights for Vernakalant to Cardiome
Biopharmaceuticals Cardiology

HSMN NewsFeed - 20 Sep 2012
Innovative Pulmonary Solutions Names Dennis Wahr, M.D., as President and CEO and Announces Series B Financing Milestone
Devices Venture Capital Personnel

HSMN NewsFeed - 2 Jul 2012
BG Medicine, Inc. Appoints Bill Densel, General Manager, CardioSCORE
Diagnostics Cardiology Personnel

HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 25 May 2012
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
Devices Interventional Cardiology Endocrinology

HSMN NewsFeed - 16 May 2012
Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries
Devices Interventional Cardiology

HSMN NewsFeed - 27 Apr 2012
Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Apr 2012
Boston Scientific Announces CE Mark and European Launch of Emerge(TM) PTCA Dilatation Catheter
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 5 Mar 2012
diaDexus Launches PLAC(R) Test for Lp-PLA(2) Activity in Europe
Diagnostics Cardiology

HSMN NewsFeed - 25 Jan 2012
New FDA Approved Labeling For VYTORIN(R) (Ezetimibe/Simvastatin) Includes Results From the Study of Heart and Renal Protection (SHARP) in Patients With Moderate to Severe Chronic Kidney Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 18 Jan 2012
diaDexus, Inc. Names Jean-Frederic Viret, Ph.D. Chief Financial Officer
Diagnostics Personnel

HSMN NewsFeed - 9 Nov 2011
Cerebral Stethoscope Offers New Tool for Early Detection of Aneurysms
Devices

HSMN NewsFeed - 25 Jul 2011
Baxter Announces FDA Approval of Subcutaneous Route of Administration for GAMMAGARD LIQUID for Patients with Primary Immunodeficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 13 Jun 2011
Pathway Medical Technologies Expands JETSTREAM G3 SF Family With FDA 510(k) Clearance for 1.6 mm Catheter
Devices Interventional FDA

HSMN NewsFeed - 18 May 2011
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
Devices Interventional Cardiology

HSMN NewsFeed - 28 Mar 2011
Pathway Medical Technologies Announces Enrollment of First Patient in JETSTREAM G3 Calcium Study
Devices Interventional

HSMN NewsFeed - 1 Feb 2011
Atherotech Diagnostics Lab Taps Mize as Vice President of Regulatory Affairs
Diagnostics Personnel

HSMN NewsFeed - 25 Jan 2011
Respected Gynecologist, Lipidologist Joins Atherotech Diagnostics Lab Medical Advisory Board
Diagnostics Cardiology Personnel

HSMN NewsFeed - 18 Jan 2011
Cook Medical’s Ongoing Drug-Eluting Peripheral Stent Trial Shows Consistent Outcomes Over 24 Months Compared to One-Year Data
Devices Interventional

HSMN NewsFeed - 2 Dec 2010
OrbusNeich's Genous Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents
Devices Interventional Cardiology

HSMN NewsFeed - 29 Nov 2010
Amarin's AMR101 Meets Pivotal Phase 3 Study Endpoints With Highly Statistically Significant Reductions in Triglycerides at 4 Gram and 2 Gram Doses in MARINE Trial With No Statistically Significant Increase in LDL-C and Safety Profile Similar to Placebo
Biopharmaceuticals

HSMN NewsFeed - 24 Nov 2010
Marvin Slosman Appointed President of Itamar-Medical Inc., North America
Devices Personnel

HSMN NewsFeed - 2 Nov 2010
Atrium Announces Completion of Patient Enrollment for the iCARUS Covered Stent Trial for PAD Patients Who Suffer Acute or Chronic Leg Pain
Devices Interventional

HSMN NewsFeed - 21 Oct 2010
Cerenis Therapeutics raises additional €10 million to close €50 million Series C financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Oct 2010
Talecris Biotherapeutics Receives FDA Approval for Gamunex(R)-C
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Sep 2010
Celera Signs Agreement with Abbott for Distribution of CE-marked KIF6 Test to Identify Patients at Risk of Coronary Heart Disease
Diagnostics Cardiology Distribution

HSMN NewsFeed - 6 Aug 2010
Medtronic Completes Enrollment in Clinical Study of Complete SE(R) (Self-Expanding) Vascular Stent
Devices Interventional

HSMN NewsFeed - 5 Aug 2010
First Patient Treated with Medtronic's Valiant(R) Thoracic Stent Graft in Aortic Dissection Trial
Devices Interventional Cardiology

HSMN NewsFeed - 2 Aug 2010
Aragon Pharmaceuticals Appoints Richard A. Heyman CEO
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Jul 2010
Hotspur Technologies Receives FDA 510(k) Clearance for First Three Product Lines Based on the Company's Unique Technology
Devices FDA

HSMN NewsFeed - 26 Jul 2010
Cerenis Therapeutics raises 40 million in series C financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 12 Jul 2010
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
Devices Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 17 Jun 2010
Micrus Endovascular Receives Approval to Market DeltaPaq and DeltaPlush Microcoils in Japan
Devices Interventional Neurology Regulatory

HSMN NewsFeed - 25 May 2010
Boston Scientific Announces CE Mark and FDA Approval of NC Quantum Apex Balloon Catheter
Devices FDA Interventional Cardiology Regulatory

HSMN NewsFeed - 27 Apr 2010
CRESTOR(TM) Gains New EU Indication to Prevent Major Cardiovascular Events in High Risk Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Apr 2010
Medtronic Receives FDA Approval for New Indication for Complete(R) SE Vascular Stent
Devices Interventional FDA

HSMN NewsFeed - 21 Apr 2010
Medtronic Completes Acquisition of Invatec and Affiliated Companies
Devices Cardiology Mergers & Acquisitions

HSMN NewsFeed - 13 Apr 2010
Baxter and New York-Presbyterian/Weill Cornell Announce 18-Month Data from Phase II Study of GAMMAGARD in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Mar 2010
Omthera Pharmaceuticals, Inc. Closes a $6.5M Series A led by Sofinnova Partners to Advance Epanova, a Prescription Omega 3 Therapy
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 20 Jan 2010
Lantheus Medical Imaging, Inc. Launches ABLAVAR (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent
Biopharmaceuticals Radiology

HSMN NewsFeed - 5 Jan 2010
New Analysis Showed Effient(R) Cost-Effective Compared with Clopidogrel for Patients with Acute Coronary Syndromes Undergoing PCI
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 23 Nov 2009
Atrium Announces 100th Patient Was Enrolled in the iCARUS Trial
Devices Interventional

HSMN NewsFeed - 18 Nov 2009
New Updates to AHA/ACC/SCAI Clinical Guidelines Recommend Treatment with Effient(R) for Patients with Acute Coronary Syndromes Managed with PCI
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Oct 2009
Arginetix Closes $10.75 Million Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 1 Oct 2009
Verathon(R) Helps Physicians Identify the Presence of Abdominal Aortic Aneurysms with New AortaScan(TM) Brand of Portable Ultrasound Aortic Measurement Instruments
Devices

HSMN NewsFeed - 24 Sep 2009
Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks
Devices Interventional Cardiology

HSMN NewsFeed - 24 Sep 2009
Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
Devices Cardiology

HSMN NewsFeed - 21 Sep 2009
New Zilver PTX Drug-Eluting Stent from Cook Medical Could Greatly Reduce Need for Leg Amputations and Bypass Surgery for European Patients
Devices Interventional

HSMN NewsFeed - 27 Aug 2009
NeuroVasx Receives Canadian Approval for cPAX Aneurysm Treatment System
Devices Interventional Neurology Regulatory

HSMN NewsFeed - 25 Aug 2009
TomTec Extends the CardioArena Product Portfolio with a Vascular Analysis Solution
Devices Cardiology

HSMN NewsFeed - 24 Aug 2009
Micrus Endovascular Signs Licensing and Development Agreement for Flow Diversion Technology
Devices Neurology Interventional

HSMN NewsFeed - 23 Jul 2009
Micrus Endovascular Announces Positive DeltaPaq Microcoil Study Results
Devices Neurology Interventional

HSMN NewsFeed - 9 Jul 2009
Merck & Co., Inc. and Portola Enter Worldwide License Agreement to Develop and Commercialize Betrixaban, a Novel Investigational Oral Anticoagulant for Cardiovascular Disease
Biopharmaceuticals Licensing

HSMN NewsFeed - 18 Jun 2009
Calcionics Appoints Daniel O. Wilds Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jun 2009
VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 11 Jun 2009
First U.S. Placement of New Smaller AAA Endovascular Graft Introduction System Solidifies Cook Medical as Market Leader in Minimally Invasive Endovascular Aneurysm Repair
Devices Interventional

HSMN NewsFeed - 4 Jun 2009
Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
Biopharmaceuticals

HSMN NewsFeed - 21 May 2009
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 May 2009
Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT Falcon at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 8 May 2009
New Data Shows Blood Pressure Reduction Therapy With BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
Biopharmaceuticals

HSMN NewsFeed - 8 May 2009
New Data Shows AZOR(R) (Amlodipine and Olmesartan Medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2009
NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
Devices Neurology Interventional Regulatory

HSMN NewsFeed - 16 Mar 2009
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
Biopharmaceuticals

HSMN NewsFeed - 23 Feb 2009
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 19 Feb 2009
CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 3 Feb 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 7 Jan 2009
Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico
Biopharmaceuticals

HSMN NewsFeed - 31 Dec 2008
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Dec 2008
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
Biopharmaceuticals Radiology

HSMN NewsFeed - 15 Dec 2008
FDA Approves Boston Scientific's Express(R) SD Renal Stent System
Devices Interventional FDA

HSMN NewsFeed - 24 Nov 2008
Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
Biopharmaceuticals

HSMN NewsFeed - 10 Nov 2008
FDA Approves Boston Scientific's Apex(TM) PTCA Dilatation Catheter
Devices Interventional Cardiology FDA

HSMN NewsFeed - 4 Nov 2008
Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
Diagnostics Cardiology Distribution

HSMN NewsFeed - 23 Sep 2008
Micrus Endovascular Announces Launch of Innovative DeltaPaq Microcoil System
Devices Interventional Neurology

HSMN NewsFeed - 22 Sep 2008
CytRx Corporation Completes Acquisition of Innovive Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Sep 2008
Micrus Endovascular Launches Neuropath Guide Catheter
Devices Neurology Interventional

HSMN NewsFeed - 15 Sep 2008
FDA Grants Approval to Talecris Biotherapeutics for Gamunex(R) as a Treatment for Neurological Disorder CIDP in the United States
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 15 Sep 2008
NicOx announces second naproxcinod pivotal phase 3 study (302) meets efficacy primary endpoints and supports non-detrimental blood pressure effect
Biopharmaceuticals

HSMN NewsFeed - 9 Sep 2008
Brigham and Women's Hospital and Celera Publish Results Demonstrating That Carriers of a Variant of the LPA Gene Have More Than Two-Fold Higher Risk of Major Cardiovascular Events and That This Risk is Eliminated by Aspirin Therapy
Cardiology

HSMN NewsFeed - 2 Sep 2008
First Patient Enrolled in Study Evaluating S.M.A.R.T. (R) Nitinol Self-Expandable Stent System in Leg Disease
Devices Interventional

HSMN NewsFeed - 2 Sep 2008
Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib
Devices Cardiology

HSMN NewsFeed - 14 Aug 2008
Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
Biopharmaceuticals

HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jul 2008
Micrus Endovascular Receives FDA Approval for Intracranial Stent Clinical Trial
Devices Neurology Interventional FDA

HSMN NewsFeed - 10 Jul 2008
Micrus Endovascular Receives Approval to Market Cerecyte Microcoils in Japan
Devices Regulatory Neurology Interventional

HSMN NewsFeed - 8 Jul 2008
Summit Doppler Announces the Seated ABI for the Diagnosis of Peripheral Arterial Disease
Devices

HSMN NewsFeed - 23 Jun 2008
Micrus Endovascular Announces CE Mark for PHAROS Vitesse Stent
Devices Neurology Interventional Regulatory

HSMN NewsFeed - 13 Jun 2008
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
Biopharmaceuticals

HSMN NewsFeed - 5 Jun 2008
Positive Clinical Data Evaluating the Micrus Endovascular Cerecyte Microcoil Published in Peer-Reviewed Journals
Devices Neurosurgery Interventional

HSMN NewsFeed - 4 Jun 2008
Loic Maurel Joins Exonhit Therapeutics to Become CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2008
Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
Diagnostics Cardiology

HSMN NewsFeed - 8 May 2008
FDA Grants Priority Review of Gamunex(R) as a Treatment for Neurological Disorder CIDP
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2008
Prescient Medical, Inc. to Present Data on Identification and Treatment of Rupture-Prone Coronary Plaques at EuroPCR 2008
Devices Interventional Cardiology

HSMN NewsFeed - 5 May 2008
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
Devices Interventional

HSMN NewsFeed - 1 May 2008
Esperion Therapeutics Completes $22.75 M Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Apr 2008
Micrus Endovascular and Chemence Medical Products Sign Development Agreement for Liquid Embolic Products
Devices Neurology Interventional

HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Raises $25 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Apr 2008
John D. Baxter, M.D. Joins Bionovo's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Apr 2008
AtheroGenics Announces Encouraging Interim Results From Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 31 Mar 2008
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 31 Mar 2008
First Statin Monotherapy to Achieve Regression of Coronary Atherosclerosis by Angiography in a Major Clinical Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 31 Mar 2008
Update on ACHIEVE: A Study of Merck's Investigational Extended-Release Niacin/Laropiprant (CORDAPTIVE(TM))
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 Mar 2008
Cook Medical Announces the Launch and First Patient Enrollment of the REFORM Clinical Trial
Devices Interventional

HSMN NewsFeed - 20 Feb 2008
Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
Devices Interventional FDA

HSMN NewsFeed - 19 Feb 2008
diaDexus Receives FDA Clearance for Automated Blood Test That Identifies Stroke & Heart Attack Risk
DIagnostics Cardiology FDA

HSMN NewsFeed - 7 Feb 2008
Positive Results from Phase III Trial of Gamunex(R) in Patients with CIDP
Biopharmaceuticals

HSMN NewsFeed - 23 Jan 2008
Robert A. Scott, M.D., Appointed Chief Medical Officer of Cerenis Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jan 2008
VIA Pharmaceuticals Names Rebecca Taub Senior Vice President of Research and Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Jan 2008
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
Biopharmaceuticals Cardiology

HSMN NewsFeed - 18 Dec 2007
Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Dec 2007
Anthera Pharmaceuticals Names Christopher P. Lowe Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Dec 2007
FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Nov 2007
Corgenix Releases Clinical Trial Data on AtherOx(TM)
Diagnostics

HSMN NewsFeed - 9 Nov 2007
CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol
Biopharmaceuticals FDA Cardiology

HSMN NewsFeed - 7 Nov 2007
Rifalazil Trial (PROVIDENCE-1) Fails to Provide Significant Clinical Benefit in Patients With Peripheral Arterial Disease
Biopharmaceuticals

HSMN NewsFeed - 7 Nov 2007
New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Nov 2007
Cleveland Clinic Study Suggests Failure of HDL-Raising Drug Torcetrapib is Likely Compound Specific
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Nov 2007
New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 25 Oct 2007
VIA Pharmaceuticals Expands Clinical Trial Program for VIA-2291 in Acute Coronary Syndrome
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Oct 2007
Edwards' Resilient Trial Demonstrates Statistically Superior Results for Treating Peripheral Arterial Disease in the Leg
Devices Interventional

HSMN NewsFeed - 18 Oct 2007
AtheroGenics Announces Change in Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Oct 2007
Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease
Diagnostics Cardiology

HSMN NewsFeed - 10 Oct 2007
Amarin Announces Initiation of Cardiovascular Development Strategy
Biopharmaceuticals

HSMN NewsFeed - 24 Sep 2007
New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
Devices Interventional FDA

HSMN NewsFeed - 10 Sep 2007
STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 10 Sep 2007
Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 2 Sep 2007
New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Sep 2007
Merck's Investigational Lipid-Modifier, CORDAPTIVE(TM) (ER niacin/laropiprant), Positively Affected Key Lipid Parameters With Less Flushing, In Data from Phase III Study
Biopharmaceuticals Drug Delivery Cardiology

HSMN NewsFeed - 28 Aug 2007
Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Aug 2007
Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
Cardiology

HSMN NewsFeed - 22 Aug 2007
Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
Biopharmaceuticals

HSMN NewsFeed - 22 Aug 2007
Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Aug 2007
KineMed and Merck Enter Collaboration in Atherosclerosis
Biopharmaceuticals

HSMN NewsFeed - 31 Jul 2007
Gene Logic Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2007
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
Biopharmaceuticals Cardiology Mergers & Acquisitions

HSMN NewsFeed - 24 Jul 2007
Cerenis Therapeutics Announces the Addition of Three Pharmaceutical Industry Veterans to its Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Jul 2007
PreMD Signs Marketing and Distribution Agreement with AstraZeneca
Diagnostics Cardiology Licensing Distribution

HSMN NewsFeed - 12 Jul 2007
Resverlogix Corp.: Dr. Roger Newton, Co-Discoverer of Lipitor(R), Commences his Board of Directors Position
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jul 2007
Study Shows Lp-PLA2 Identifies Individuals at Highest Risk for Ischemic Stroke
Diagnostics Neurology

HSMN NewsFeed - 25 Jun 2007
Ranbaxy Launches Pravastatin Sodium 80 Mg Tablets
Biopharmaceuticals Generics

HSMN NewsFeed - 23 Jun 2007
New Study Demonstrates Colesevelam HCl Lowers Both A1C and LDL Cholesterol in Patients With Uncontrolled Type 2 Diabetes Mellitus on Metformin-Based Regimen
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 18 Jun 2007
Atherotech Names Leading High Tech Heart Disease Prevention Expert as Chief Medical Officer
Diagnostics Cardiology

HSMN NewsFeed - 16 Jun 2007
Siemens Demonstrates New Methods of Cardiovascular Risk Assessment at the American Society of Echocardiography
Devices Cardiology

HSMN NewsFeed - 7 Jun 2007
In 2009 Exonhit Aims to ask for Market Clearance in Europe for a Blood Diagnostic Test for Alzheimer's Disease
Diagnostics Neurology

HSMN NewsFeed - 6 Jun 2007
Takeda Revises ACTOS(R) (pioglitazone HCl) Prescribing Label
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 6 Jun 2007
PreMD Submits 510(k) to the FDA for Expanded Regulatory Claim for PREVU(x) POC
Diagnostics FDA

HSMN NewsFeed - 5 Jun 2007
VIA Pharmaceuticals and Corautus Genetics Complete Merger to Form VIA Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 4 Jun 2007
Corautus Genetics Stockholders Approve Merger with VIA Pharmaceuticals and Related Proposals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 May 2007
Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients
Biopharmaceuticals

HSMN NewsFeed - 3 May 2007
diaDexus Appoints Charles Patrick to Board of Directors
Diagnostics Personnel

HSMN NewsFeed - 1 May 2007
diaDexus Announces Two Key Executive Appointments
Diagnostics Personnel

HSMN NewsFeed - 1 May 2007
Viron Therapeutics Appoints Claude Benedict, M.D. as New Senior Vice President, Clinical Development and Regulatory Affairs
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Apr 2007
Two-year data for Angiotech's Vascular Wrap(TM) Paclitaxel-Eluting Mesh to be presented at European vascular symposium
Devices

HSMN NewsFeed - 25 Apr 2007
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 13 Apr 2007
First Patient Enrolled in Phase 2 'PLASMA' Trial With A-002 for Patients With Coronary Atherosclerosis
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 Apr 2007
Medtronic Combines Vascular and Cardiac Surgery Businesses
Devices Surgery Interventional Cardiology

HSMN NewsFeed - 6 Apr 2007
Abbott Announces FDA Approval of a New Coated Niaspan Tablet
Biopharmaceuticals FDA

HSMN NewsFeed - 4 Apr 2007
Protemix Raises US$14.5 Million in First Close of Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Mar 2007
Daiichi Sankyo, Inc. Announces Filing For WelChol Label Change to Include Ezetimibe Efficacy Data
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Mar 2007
Two New Imaging Studies Show Higher Dose Lipitor Stopped the Progression of Atherosclerosis
Biopharmaceuticals Cardiology

HSMN NewsFeed - 25 Mar 2007
First Study to Show Positive Benefit on Atherosclerosis for People With Early Signs of Diseased Arteries
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 Mar 2007
Cambridge Heart Announces Co-Marketing Agreement with St. Jude Medical and a $12.5 Million Equity Investment
Devices Cardiology

HSMN NewsFeed - 20 Mar 2007
Anthera Pharmaceuticals, Inc. Announces Appointment of Dr. James Pennington as Executive Vice President & Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Mar 2007
Anthera Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board for Respiratory and Acute Care Programs
Biopharmaceuticals Personnel

HSMN NewsFeed - 7 Mar 2007
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 28 Feb 2007
Vascular BioSciences Extends Patent Portfolio
Biopharmaceuticals

HSMN NewsFeed - 28 Feb 2007
Schering-Plough Announces Executive Changes in Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Feb 2007
Corautus Genetics and VIA Pharmaceuticals Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Feb 2007
SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Feb 2007
Dr. David D. Waters Joins Anthera Pharmaceuticals as Cardiovascular Research Fellow
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Feb 2007
AtheroGenics Announces Promotion of Charles A. Deignan to Vice President of Finance and Administration
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jan 2007
Par Pharmaceutical Receives Approval of Generic Inderal-LA(R)
Biopharmaceuticals Cardiology Generics FDA

HSMN NewsFeed - 9 Jan 2007
Anthera Receives IND Approval from FDA to Begin Phase 2 'IMPACTS' Trial With A-001 for Prevention of Acute Chest Syndrome in Patients with Sickle Cell Disease
Biopharmaceuticals

HSMN NewsFeed - 8 Jan 2007
Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2007 Goals at JPMorgan Healthcare Conference
Biopharmaceuticals

HSMN NewsFeed - 4 Jan 2007
Anthera Receives FDA Approval to Begin Phase 2 'PLASMA' Trial With A-002 for Patients With Coronary Atherosclerosis
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 2 Jan 2007
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Dec 2006
Data Recently Published in Mayo Clinic Proceedings Showed VYTORIN(R) (ezetimibe/simvastatin) Superior to Lipitor (atorvastatin) in Reducing LDL ''Bad'' Cholesterol in Patients with Type II Diabetes at the Dose Comparisons Studied
Biopharmaceuticals

HSMN NewsFeed - 14 Dec 2006
Sheldon A. Schaffer, Ph.D. Joins Aastrom as Vice President, Corporate Development & Intellectual Property
Regenerative Medicine Personnel

HSMN NewsFeed - 13 Dec 2006
Merck Wins Federal VIOXX(R) Product Liability Case
Biopharmaceuticals Litigation

HSMN NewsFeed - 7 Dec 2006
New Billing Code and Medicare Payment Recommendation Issued for Lp-PLA2 Testing
Diagnostics Cardiology Reimbursement

HSMN NewsFeed - 7 Dec 2006
Xenon Enters Into Anemia Collaboration With Roche
Biopharmaceuticals

HSMN NewsFeed - 30 Nov 2006
Cardium Announces Formation of Scientific Advisory Board
Devices Personnel

HSMN NewsFeed - 24 Nov 2006
Aloka Co., Ltd. Introduces New Version 5 of ProSound Alpha 10 at RSNA
Devices Radiology

HSMN NewsFeed - 14 Nov 2006
Studies Presented at AHA Confirm Role of Inflammatory Marker Lp-PLA2 in Assessing Cardiovascular Risk and in Secondary Prevention
Diagnostics Cardiology

HSMN NewsFeed - 13 Nov 2006
New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of Atherosclerosis as Indicated by CIMT in Patients With Type 2 Diabetes
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
First Study to Evaluate WelChol/Ezetimibe and Simvastatin Effect on LDL-C Finds Additional Lipid Parameter Benefits
Biopharmacetuicals Cardiology

HSMN NewsFeed - 13 Nov 2006
WelChol and Ezetimibe Combination Therapy Provides Significant LDL-C Reductions
Biopharmaceuticals

HSMN NewsFeed - 9 Nov 2006
Angiotech's Vascular Wrap(TM) trial results demonstrate reduced incidence of amputation
Devices

HSMN NewsFeed - 8 Nov 2006
diaDexus Reports Study Showing Lp-PLA2 Is an Independent Marker of Coronary Artery Disease and Death
Diagnostics Cardiology

HSMN NewsFeed - 24 Oct 2006
Study Shows Inflammatory Enzyme Lp-PLA2 Predicts Recurrent Stroke
Diagnostics Cardiology Neurology

HSMN NewsFeed - 2 Oct 2006
Xenon and Takeda Announce Agreement To Develop and Commercialize XEN401 for Pain in Japan and Certain Asian Countries
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2006
Merck Revises Regulatory Filing Timeline for MK-0524B, an Investigational Fixed-Dose Combination of MK-0524A and Simvastatin
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Sep 2006
Published Data Show Kereos Technology Specifically Targets Arterial Plaque
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Sep 2006
Medtronic Achieves Key Milestones in Rapidly Growing Peripheral Vascular Business
Devices Interventional

HSMN NewsFeed - 27 Sep 2006
PreMD's PREVU(x) LT Cleared For Sale in Canada
Diagnostics Cardiology Regulatory

HSMN NewsFeed - 27 Sep 2006
Merck and FoxHollow Technologies Expand Scope of Worldwide Strategic Research Collaboration
Devices Interventional Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2006
Arena Pharmaceuticals Announces Update on Partnership With Merck in Development of Niacin Receptor Agonists
Biopharmaceuticals

HSMN NewsFeed - 18 Sep 2006
PreMD's PREVU(x) LT Cleared For Sale in Europe
Diagnostics Cardiology Regulatory

HSMN NewsFeed - 15 Sep 2006
King Pharmaceuticals Reports DREAM Data on Ramipril
Biopharmaceuticals Cardiology

HSMN NewsFeed - 13 Sep 2006
Anthera Pharmaceuticals Secures $36M Venture Financing to Initiate Clinical Programs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 7 Sep 2006
The New England Journal of Medicine Publishes the STEEPLE Study Which Demonstrated Superior Safety Profile of LOVENOX(R)(Enoxaparin Sodium Injection) Vs. Unfractionated Heparin in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention (PCI)
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 6 Sep 2006
Anthera Licenses Portfolio of Anti-Inflammatory Products From Eli Lilly and Company and Shionogi & Co., Ltd.
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Sep 2006
New EXPLORER Results Show Patients Achieved Dramatic Reductions in C-Reactive Protein And LDL-C Levels With CRESTOR Combination Therapy
Biopharmaceuticals Cardiology

HSMN NewsFeed - 12 Jul 2006
Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 6 Jul 2006
AtheroGenics Announces Promotion of Joseph M. Gaynor, Jr. to Senior Vice President
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Jun 2006
CoTherix Licenses Exclusive Rights to Develop and Commercialize Oral and Inhaled Formulations of Fasudil for the Treatment of PAH and Stable Angina in North America and Europe From Asahi Kasei Pharma
Biopharmaceuticals Licensing

HSMN NewsFeed - 22 Jun 2006
New Data Shows CRESTOR(R) Helped African American, Hispanic American and South Asian American Patients Significantly Lower LDL-C and Achieve Cholesterol Goals
Biopharmaceuticals Cardiology

HSMN NewsFeed - 1 Jun 2006
Lipid Sciences, Inc. Initiates Human Clinical Trial of Plasma Delipidation System
Devices Cardiology

HSMN NewsFeed - 1 Jun 2006
Isis Pharmaceuticals Receives Orphan Drug Status for ISIS 301012 for the Treatment of Homozygous Familial Hypercholesterolemia
Biopharmaceuticals FDA

HSMN NewsFeed - 24 May 2006
AtheroGenics Names Brian Blakey as Vice President of Marketing
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2006
Biovail to Promote Novartis' Lescol(R) Franchise in Canada; Lescol(R) Provides Treatment Option for Patients Who Need a Statin to Reduce Cardiovascular Risk
Biopharmaceuticals

HSMN NewsFeed - 15 May 2006
Pfizer's Lipitor Provides Greater Reductions in Heart Attack, Stroke and Cardiovascular Procedures at an Overall Cost Savings Compared to Zocor, New Analysis Shows
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 May 2006
CRESTOR Helped More Patients Reach Goal in MERCURY II Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 11 May 2006
AtheroGenics Announces Promotions of Three Senior Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 9 May 2006
Pharmacyclics to Submit New Drug Application for Xcytrin(R) for Treatment of Lung Cancer Patients With Brain Metastases
Biopharmaceuticals Oncology

Return to NewsFeed

Additional items found! 266

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 266 additional stories matching:
atherosclerosis
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.